PCT

EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company")
announced today that the Company has received a favorable review from the Patent
Cooperation Treaty ("PCT") Examiner for its powderREV(TM) III patent
application, which includes a novel recycling system. The design provides the
EnWave with the ability to dehydrate enzymes, probiotics and biopharmaceuticals
in a more efficient manner either continuously or in batch amounts. This
flexibility aligns well with the industry's current processing best practices. 


The views expressed by the PCT Examiner are not binding on examiners in any
patent office. However, they are a guide to whether national patent offices are
likely to raise significant objections to granting patents having claims like
those pending in the PCT application. The examiner indicated that all three
requirements for patentability, namely, novelty, inventive step and industrial
applicability, are satisfied by all the claims submitted in EnWave's
application. 


"Over the past year, EnWave has received strong interest from pharmaceutical,
enzyme and probiotic companies," stated Dr. Tim Durance, Chairman and Co-CEO,
EnWave Corporation. "The ability to provide a flexible platform for their
dehydration needs is of paramount importance as each material requires specific
processing parameters."


EnWave holds an expanding intellectual property portfolio designed to protect
its technology and knowledge base. The Company's patented technology combines
microwave energy with vacuum pressure to control the temperature at which
liquids boil and subsequently evaporate. This form of liquid evaporation is a
major advancement in the dehydration of food and biological materials. REV
technology is currently being developed to replace freeze drying and compete
directly with spray and air drying.


About EnWave 

EnWave Corporation is a Vancouver-based industrial technology company developing
commercial applications for its proprietary Radiant Energy Vacuum (REV)
dehydration technology. The company recently licensed REV technology to Milne
Fruit Products Inc, its first major U.S. customer, to support a launch of
healthy berry snacks and powders across most major markets in North America.
More recently, EnWave licensed REV technology to one of its Tier 1 multinational
partners from the list below. In addition, EnWave has entered a wide range of
research and collaboration agreements with an expanding list of multinational
partners, including Nestle, Kellogg's, Grupo Bimbo, Grimmway Farms, Ocean Spray
Cranberries, Hormel, Bonduelle, Cherry Central, Sun-Maid Growers and Merck.
EnWave is introducing REV as a new dehydration standard in the food and
biological material sectors: potentially faster and cheaper than freeze drying,
with better end product quality than air drying or spray drying.


EnWave currently has six REV platforms: commercial-scale nutraREV(R) and
MIVAP(R) are used in the food industry to dry fruits, vegetables, meat, herbs
and seafood quickly and at low-cost, while maintaining high levels of nutrition,
taste, texture and colour. The Company is also developing powderREV(TM) for bulk
dehydration of food cultures, probiotics and fine biochemicals such as enzymes;
quantaREV(TM) for continuous, high-volume low-temperature drying of pastes,
gels, liquids, or particulates; and bioREV(TM) and freezeREV(TM) as new methods
to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies.
More information about EnWave is available at www.enwave.net.


EnWave Corporation

Dr. Tim Durance, Chairman & Co-CEO

Safe Harbour for Forward-Looking Information Statements: This press release may
contain forward-looking information based on management's expectations,
estimates and projections. All statements that address expectations or
projections about the future, including statements about the Company's strategy
for growth, product development, market position, expected expenditures and
financial results are forward-looking statements. These statements are not a
guarantee of future performance and involve a number of risks, uncertainties and
assumptions. There is no guarantee that the Company's REV technology can or will
improve processes in the target industry; even if the Company's REV technology
can be used as described in this document, there is no guarantee that such use
will result in orders for the Company's REV technology. All figures comparing
REV technologies to freeze drying or other dehydration technologies are provided
as examples of data obtained through the Company's own scientific and testing
programs; each product must be tested individually to determine the benefits of
using REV.

(TSXV:PCT)
Historical Stock Chart
From May 2024 to Jun 2024

(TSXV:PCT)
Historical Stock Chart
From Jun 2023 to Jun 2024